Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Women With Uterine Fibroids
CHMP opinion recommending approval based on data from the Phase 3 LIBERTY program in women…
CHMP opinion recommending approval based on data from the Phase 3 LIBERTY program in women…
NEW YORK, May 21, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB:…
PMN310 potential best in class antibody candidate for treatment of Alzheimer’s disease TORONTO and CAMBRIDGE,…
CAMBRIDGE, Mass., May 21, 2021 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”), an…
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) recently learned its…
European Key Opinion Leaders to Participate in Event REDWOOD CITY, Calif., May 21, 2021 (GLOBE…
SUZHOU, China and PALO ALTO, Calif., May 21, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc….
Laboratory and pre-clinical models of whole-lung engineering inform roadmap for building a functional lung alveolus,…
Provides educational resources for both patients and healthcare providers SAN DIEGO, May 21, 2021 (GLOBE…
Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen’s efforts to…
JENA, Germany, May 21, 2021 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 21, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics…
MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
PHILADELPHIA, May 21, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), today announced two posters…
Attendance in person is not permitted LONDON, May 21, 2021 (GLOBE NEWSWIRE) — Autolus Therapeutics…
NX-5948, a potent selective degrader of BTK, significantly reduces inflammation in a model of autoimmune…
BioNTech is committed to contributing to the UN Sustainable Development Goals (SDGs), particularly the promotion…
BOSTON, May 21, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company…
MIRAMAR, Fla., May 21, 2021 (GLOBE NEWSWIRE) — HAVRION, a company committed to creating advanced…
More than 1,400 New Dealer Enrollments in March and April; Scott Johnston Named Chief Operating…